$SNPS

Synopsys shares jump on robust growth outlook, OpenAI and AWS deals

Synopsys (SNPS) shares rose 10% after the company forecast fiscal 2027 revenue of $11.10B-$11.20B, above estimates, and announced deals with OpenAI and AWS. It also plans a $1B share buyback and targets 15% annual revenue growth through 2030.

Original reporting
Published Oct 1, 2026, 4:21 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 1, 2026, 4:30 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefMarket movers
Primary signal
$SNPS
Bullish
high confidence
Mentioned
$SNPS
Relevance
9/10
AlphAI data visualization · based on investing.com
Decision brief

The 30-second read

$SNPSBullishHigh
01

Why it matters

The guidance and deals are fresh, primary disclosures that moved the stock 10% on the day.

02

Market read

Strong FY2027 outlook and high‑value AI partnerships drive a notable share rally.

03

What to watch

Potential competition from emerging EDA tools and macro‑economic slowdown.

Relevance 9/10Novelty 9/10Timing: pre‑market today

Background

Synopsys held its investor day, presented long‑term growth targets and disclosed new AI‑related deals.

Company-level read

Ticker impact

$SNPSBullishHigh confidence
Context

Synopsys announced FY2027 revenue of $11.10‑$11.20B and a $1B buyback, driving a 10% share jump.

Expected impact

likely upward pressure as investors price in higher revenue outlook and the $1B buyback.

Evidence & confidence

Guidance beats consensus by ~$300M, margin expansion target, and a $1B+ AWS licensing deal provide clear upside catalysts.

Market effects

Positive for EDA and AI‑chip design software sector.

U.S. tech stocks may see modest lift.

Reinforces demand for AI‑driven chip design worldwide.

Counterpoint

If execution falls short, the high guidance could lead to disappointment.

Key entities

  • Synopsys

    EDA software provider.

  • Amazon Web Services

    AWS signed a multi‑year licensing deal with Synopsys.

  • OpenAI

    Partnered with Synopsys on an AI model for chip design.

Related articles

$SNPSHigh

Synopsys Stock Rises 9%

Synopsys (SNPS) stock rose 9.38% to $475.74 on Thursday, following a strategic partnership with OpenAI to develop GPT-Synopsys, an AI model for semiconductor design. The company's stock traded between $462.00 and $493.30 with higher-than-average volume. The 52-week range is $362.55 to $539.48.

$ACNMed

Stocks making the biggest moves midday: Accenture, Synopsys, United Therapeutics, Vicor and more

Accenture rose 18% after Q4 revenue of $18.7B beat estimates. McCormick's Q3 results topped expectations but shares fell 2% amid Unilever's acquisition. McKesson gained 4% on reaffirmed guidance and a CVS Health partnership. United Therapeutics climbed 6% after a court ruling, while Liquidia dropped 15%. Constellation Energy gained 3% on a 20-year Amazon deal. Synopsys jumped 8% with 2027 revenue targets. Sigma Lithium slid 16% after halting production.

$SNPSHighAI 9/10

Why Synopsys Stock Soared on Thursday

Synopsys (SNPS) stock rose 12.5% after the company projected 2027 revenue up to $11.2B, higher than analysts' $9.7B estimate for 2026. It expects 2027 free cash flow of $3.1B and operating margins of 20.7%. GAAP EPS is forecast at $8.16-$8.61, while non-GAAP EPS is projected at $19.04-$19.12.

$SNPSMedAI 8/10

Synopsys Stock Jumps As AI Deals And Targets Power SNPS

Synopsys Inc. (NASDAQ: SNPS) stock rose 9.91% on October 1, 2026, driven by strong AI-chip design demand and upbeat guidance. The company reported $7.05B in trailing revenue, 72% gross margin, and guided to 15% annual revenue growth, targeting $11.15B in FY27. Recent partnerships with Amazon, OpenAI, and TSMC bolster its AI and chip design narrative. HSBC upgraded SNPS to Buy with a $700 target.

$SNPSHighAI 8/10

Synopsys Stock Jumps As AI Deals And Targets Impress Wall Street

Synopsys Inc. (NASDAQ: SNPS) shares rose 10.06% on October 1, 2026, driven by strong AI-chip design demand and upbeat guidance. The company reported $7.05B in revenue, 72.4% gross margin, and 30%+ EBITDA margin. SNPS projected 15% revenue growth for FY27, targeting $11.15B, and announced AI partnerships with Amazon and OpenAI. HSBC upgraded SNPS to Buy with a $700 target, citing high-growth AI potential.